Core Viewpoint - The article discusses a class action lawsuit against Six Flags Entertainment Corporation, alleging that the company and its executives misled investors regarding the financial health and operational needs of the company prior to its merger with Cedar Fair, L.P. [1][3] Company Overview - Six Flags Entertainment Corporation, previously known as CopperSteel HoldCo, Inc., is an amusement park operator that has faced significant operational challenges and financial misrepresentation allegations [2][3]. Merger Details - The merger between Legacy Six Flags and Cedar Fair closed on July 1, 2024, with Six Flags stock initially trading above $55 per share [4]. - Following the merger, the stock price plummeted to as low as $20 per share, representing a nearly 64% decline [4]. Allegations of Misrepresentation - The lawsuit claims that the registration statement for the merger failed to disclose chronic underinvestment in Legacy Six Flags, which required millions in additional capital and operational expenditures to maintain competitiveness in the amusement park market [3]. - It is alleged that the new CEO, Selim Bassoul, implemented significant cost-cutting measures that degraded operational competence and guest experience, further exacerbating the company's financial issues [3]. Legal Proceedings - The class action lawsuit is titled "City of Livonia Employees' Retirement System v. Six Flags Entertainment Corporation" and has a deadline of January 5, 2026, for potential lead plaintiffs to come forward [1][2].

Core Viewpoint - A class action securities lawsuit has been filed against James Hardie Industries plc, alleging securities fraud that negatively impacted investors between May 20, 2025, and August 18, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that James Hardie Industries made false statements and concealed adverse facts regarding its North America segment, including deteriorating consumer demand and growth, which was primarily driven by overstocking rather than actual consumer demand [2]. - The complaint highlights that excessive inventory was present at James Hardie's North America distributors as a result of these misleading practices [2]. Group 2: Investor Information - Investors who suffered losses during the specified period have until December 23, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving in this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Avantor, Inc. alleging securities fraud that negatively impacted investors between March 5, 2024, and October 28, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Avantor's competitive positioning was misrepresented, indicating it was weaker than publicly stated [2]. - It is alleged that Avantor faced negative impacts from increased competition, which were not disclosed by the defendants [2]. - The representations made by the defendants regarding the company's business, operations, and prospects are claimed to be materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 29, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and there are no out-of-pocket costs for class members [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as a leading firm in securities litigation [4]. - The firm has been ranked in the Top 50 Report by ISS Securities Class Action Services for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against Fortinet, Inc. for alleged securities fraud affecting investors between November 8, 2024, and August 6, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that Fortinet misrepresented the profitability of its product refresh cycle, stating it would be more lucrative than it actually was, as it involved old products that constituted a "small percentage" of the Company's business [2] - Defendants allegedly concealed the true number of FortiGate firewalls eligible for upgrades and misled investors about the momentum of the refresh cycle, which was pushed through aggressively in a short time frame [2] Group 2: Investor Information - Investors who suffered losses during the specified period have until November 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3] Group 3: Law Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States, with over 70 employees dedicated to serving clients [4]

Core Insights - Perrigo Company plc is under investigation for possible violations of federal securities laws, as announced by Levi & Korsinsky [1] - On November 5, 2025, Perrigo announced a strategic review of its infant formula business, which includes reassessing a previously announced investment of $240 million [2] - Following the announcement of the strategic review, Perrigo's stock price dropped over 25% on the same day [2] Company Developments - The strategic review aims to accelerate cash flows and optimize the impact of the portfolio [2] - The review will consider a range of alternatives for the infant formula business [2] Legal Context - Levi & Korsinsky LLP has a history of representing investors in securities litigation and has secured significant settlements for shareholders [3] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [3]

Core Viewpoint - V.F. Corporation is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between October 30, 2023, and May 20, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that V.F. Corporation made materially false and misleading statements regarding its turnaround plans, particularly concerning the Vans brand, which required significant reset actions to return to growth [2]. - Following the release of V.F. Corporation's fiscal 2025 results on May 21, 2025, it was revealed that Vans' revenue growth had significantly declined, with losses increasing from 8% to 20% in the fourth quarter [2]. - The company attributed its disappointing results to deliberate actions taken to eliminate unprofitable businesses, indicating that even without these actions, Vans would have experienced a high single-digit revenue decline [2]. Group 2: Stock Price Impact - On May 21, 2025, V.F. Corporation's stock price fell from $14.43 to $12.15 per share, marking a decline of approximately 15.8% in one day following the negative news [2]. Group 3: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 12, 2025, to request appointment as lead plaintiff in the lawsuit, although participation does not require serving in this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 4: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [4].

Core Viewpoint - A class action securities lawsuit has been filed against WPP plc, alleging securities fraud that negatively impacted investors between February 27, 2025, and July 8, 2025 [1][2] Company Performance - The lawsuit claims that WPP provided overly positive statements while concealing adverse facts about its media arm's ability to handle macroeconomic challenges, leading to a loss of market share [2] - On July 9, 2025, WPP reported a deterioration in performance for Q2 2025, attributing this to macroeconomic uncertainty and weaker new business, compounded by ongoing restructuring within WPP Media [2] - Following the trading update, WPP's stock price fell from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking a decline of approximately 18.1% in one day [2] Legal Proceedings - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in CarMax, Inc. ("CarMax, Inc." or the "Company") (NYSE: KMX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CarMax, Inc. investors who were adversely affected by alleged securities fraud between June 20, 2025 and September 24, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/carmax-inc-lawsuit-subm ...

Core Points - A class action securities lawsuit has been filed against Fluor Corporation, targeting alleged securities fraud that affected shareholders between February 18, 2025, and July 31, 2025 [2][3] Group 1: Allegations - The lawsuit claims that Fluor Corporation made false statements regarding the costs associated with its infrastructure projects, including Gordie Howe, I-635/LBJ, and I-35, which were reportedly increasing due to subcontractor design errors, price hikes, and scheduling delays [3] - It is alleged that these issues, along with a reduction in customer capital spending and client hesitance due to economic uncertainty, were significantly impacting the company's business and financial results [3] - The complaint asserts that Fluor's financial guidance for FY 2025 was unreliable, overstating the effectiveness of its risk mitigation strategies and understating the impact of economic uncertainty on its operations [3] Group 2: Next Steps for Affected Shareholders - Shareholders who experienced losses during the specified timeframe are encouraged to seek information on their rights to recovery, with no cost or obligation to participate [4] Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a history of securing substantial recoveries for shareholders and has been ranked among the top securities litigation firms in the United States for seven consecutive years [5]

Core Viewpoint - The MoonLake class action lawsuit alleges that MoonLake Immunotherapeutics and certain executives violated the Securities Exchange Act of 1934, impacting investors who purchased or acquired its common stock [1][3]. Group 1: Company Overview - MoonLake Immunotherapeutics is a clinical stage biotechnology company focused on developing therapies for inflammatory skin and joint diseases, with its sole drug candidate being sonelokimab (SLK) aimed at treating hidradenitis suppurativa (HS) [3][4]. - The commercial prospects of SLK were contingent on demonstrating efficacy comparable or superior to Union Chimique Belge's BIMZELX, an FDA-approved monoclonal antibody for HS [3]. Group 2: Allegations and Impact - The lawsuit claims that during the class period, MoonLake made false or misleading statements regarding SLK's clinical benefits, including its molecular targets and tissue penetration capabilities [4]. - On September 28, 2025, MoonLake announced that SLK failed to show competitive efficacy compared to BIMZELX in its Phase 3 VELA program, leading to a nearly 90% drop in the stock price [5].